PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Furazolidone→

Furazolidone PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
67-45-8
Molecular formula
C8H7N3O5
Molecular weight
225.16 g/mol
Drug class
Nitrofuran antibacterial and antiprotozoal agentmonoamine oxidase inhibitor properties
Mechanism of action
After bacterial reduction of its nitro group, reactive intermediates damage microbial DNA and other macromolecules. It also has monoamine oxidase-inhibiting properties that can cause clinically important food and drug interactions.
Indications / reported uses
  • Historically used for selected bacterial diarrhoeal and protozoal infections, including giardiasis, cholera and dysentery in countries where authorised; use is restricted or discontinued in many jurisdictions and should not be presented as routine contemporary therapy

Sources: NLM MeSH — Furazolidone · PubMed — Furazolidone clinical use and safety · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Furazolidone PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Furazolidone Permitted Daily Exposure (PDE) report (the Furazolidone PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Furazolidone Occupational Exposure Limit (OEL) report (the Furazolidone OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.